Download PDF

Other users also viewed these articles

Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Ocular inflammatory manifestations in patients with rheumatoid arthritis Raul E. Ruiz-Lozano; Luis Arnaldo Prida-Espaillat; Reinaldo A. Moll-Auais; Eugenia M. Ramos-Dávila; Manuel E. Quiroga-Garza; Aaron Zhao; Ali Khodor; Amr Almobayed; David Vega-Morales; Alejandro Rodriguez-Garcia;
Reumatol Clin. 2025;21:
JAK kinase inhibitors and varicella zoster virus infection in patients with rheumatoid arthritis. Systematic review of the literature Carmen Olga Sánchez González; Juan Carlos Nieto González;
Reumatol Clin. 2022;18:453-8